Table 2.
Health state categories in the Markov cohort models | Fox et al. [11] | Yao et al. [12] | Aidelsburger et al. [13] | Bond et al. [14] | Callejo et al. [15] | Bertoldi et al. [16] | Neyt et al. [17] | Colquitt et al. [18] |
---|---|---|---|---|---|---|---|---|
Short-term states | ||||||||
CRT-P implantation (operation) | √ | n.a. | n.a. | √ | √ | n.a. | √ | √ |
Complications after CRT implantation | √ | n.a. | √ | √ | n.a. | √ | ||
Death (CRT-P implantation or subsequent operation) | √ | n.a. | n.a. | √ | √ | n.a. | √ | √ |
Upgrading/switching state | ||||||||
Upgrading CRT-P to a CRT-D (operation) | √ | n.a. | √ | √ | √ | √ | ||
ICD implantation (operation) | √ | n.a. | n.a. | n.a. | n.a. | n.a. | √ | √ |
Maintenance states | ||||||||
Patient with CRT has no adverse eventsa | √ | √ | √ | √ | √ | √ | √ | √ |
Patient receiving OPT has no adverse eventsa | √ | √ | √ | √ | √ | √ | √ | √ |
Patient with ICD has no adverse eventsa | √ | n.a. | n.a. | n.a. | n.a. | √ | √ | √ |
Hospitalization—CRT-related infection | √ | √ | √ | √ | √ | √ | √ | |
Hospitalization—ICD-related infectionb | √ | n.a. | n.a. | n.a. | √ | √ | ||
(Hospitalization)—lead failure/displacement | √ | √ | √ | √ | √ | |||
HF hospitalisation | √ | √ | √ | √ | √ | √ | ||
Hospitalisation—heart transplant | √ | √ | √ | √ | ||||
Hospitalisation—CABG | √ | √ | ||||||
Hospitalisation—Radiofrequency ablation | √ | √ | ||||||
Hospitalisation—PTCA/Stent | √ | √ | ||||||
Maintenance of CRT (e.g. device/battery change) (operation) | √ | √ | √ | |||||
Long-term death states | ||||||||
Death from SDC | √ | √ | √ | √ | √ | √ | √ | √ |
Death from HF | √ | √ | √ | √ | √ | |||
Death from nCR causes | √ | √ | √ | √ |
aThis means that these events do not take place during the model cycle
bYao et al. [12] include two additional states the Coronary Care Unit (CCU) and the intensive care unit (ICU)
SDC Sudden Cardiac Death, HF Heart failure, nCR non-cardiac-related, PTCA Percutaneous Transluminal Coronary Angioplasty, n.a. not applicable